Table 3 -.

Multivariate predictors of primary, primary-assisted, and secondary patency loss.

	Primary Patency		Primary-Assisted Patency		Secondary Patency
	HR (95% CI)	p value	HR (95% CI)	p value	HR (95% CI)	p value
SFA Inflow	0.96 (0.88-1.04)	.359	1.06 (0.94-1.20)	.275	1.07 (0.95-1.21)	.212
Age	0.99 (0.98-0.99)	<.001	0.98 (0.98-0.99)	<.001	0.99 (0.98-0.99)	<.001
Female	1.14 (1.06-1.22)	<.001	1.26 (1.14-1.41)	<.001	1.26 (1.13-1.40)	<.001
Obese	0.89 (0.83-0.96)	.004	0.88 (0.79-0.98)	.027	0.88 (0.79-0.98)	.030
Smoking history	0.96 (0.89-1.03)	.313	1.03 (0.92-1.15)	.547	1.02 (0.91-1.15)	.629
Diabetes	1.03 (0.96-1.11)	.300	1.09 (0.98-1.22)	.089	1.11 (1.00-1.24)	.047
Coronary disease	1.00 (0.93-1.08)	.931	0.97 (0.86-1.08)	.586	0.96 (0.86-1.08)	.536
End-stage renal disease	0.97 (0.83-1.14)	.765	0.96 (0.76-1.21)	.740	0.96 (0.87-1.21)	.767
COPD	0.98 (0.94-1.02)	.492	0.99 (0.93-1.06)	.832	1.00 (0.93-1.07)	.933
Prior inflow procedure	1.06 (0.97-1.15)	.190	1.06 (0.92-1.21)	.396	1.04 (0.91-1.19)	.511
Prior endovascular intervention	1.19 (1.11-1.29)	<.001	1.08 (0.96-1.21)	.207	1.04 (0.93-1.17)	.442
Critical limb ischemia indication	1.21 (1.11-1.32)	<.001	1.28 (1.12-1.47)	<.001	1.26 (1.10-1.45)	.001
Tibial distal target	1.30 (1.21-1.40)	<.001	1.71 (1.53-1.90)	<.001	1.70 (1.52-1.89)	<.001
Concurrent proximal endarterectomy	1.01 (0.97-1.24)	.675	0.94 (0.84-1.06)	.320	0.94 (0.84-1.06)	.370
Concurrent infrainguinal endovascular intervention	1.10 (0.95-1.11)	.126	1.06 (0.87-1.30)	.515	1.06 (1.45-1.81)	.535
Use of prosthetic graft	1.03 (0.95-1.11)	.446	1.68 (1.50-1.87)	<.001	1.62 (1.44-1.81)	<.001
DAPT	0.98 (0.90-1.06)	.666	0.96 (0.85-1.09)	.544	0.96 (0.85-1.09)	.556
Oral anti-coagulation	1.01 (0.94-1.09)	.694	1.07 (1.02-1.14)	.465	1.12 (1.04-1.19)	.678
Statin use	0.97 (0.90-1.05)	.501	1.04 (0.92-1.16)	.531	1.03 (0.92-1.16)	.556